$328.33
3.50[1.08%]
At close: Apr 19
$328.33
0[0.00%]
After Hours: 4:06PM EDT
Humana Stock (NYSE:HUM), Analyst Ratings, Price Targets, Predictions
Humana Inc has a consensus price target of $464.28, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Wells Fargo, and Cantor Fitzgerald on April 10, 2024, April 8, 2024, and April 4, 2024. With an average price target of $377.33 between Cantor Fitzgerald, Wells Fargo, and Cantor Fitzgerald, there's an implied 14.93% upside for Humana Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Wells Fargo
Goldman Sachs
Barclays
TD Cowen
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Humana
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | HUM | Buy Now | Humana | $328.33 | 19.09% | Cantor Fitzgerald | Sarah James | → $391 | Reiterates | Neutral → Neutral | Get Alert |
| 04/08/2024 | HUM | Buy Now | Humana | $328.33 | 6.6% | Wells Fargo | Stephen Baxter | $413 → $350 | Maintains | Overweight | Get Alert |
| 04/04/2024 | HUM | Buy Now | Humana | $328.33 | 19.09% | Cantor Fitzgerald | Sarah James | → $391 | Reiterates | Neutral → Neutral | Get Alert |
| 04/03/2024 | HUM | Buy Now | Humana | $328.33 | 17.26% | Goldman Sachs | Nathan Rich | $450 → $385 | Maintains | Buy | Get Alert |
| 04/02/2024 | HUM | Buy Now | Humana | $328.33 | -5.58% | Barclays | Andrew Mok | $356 → $310 | Maintains | Equal-Weight | Get Alert |
| 04/02/2024 | HUM | Buy Now | Humana | $328.33 | 20.61% | TD Cowen | Gary Taylor | $427 → $396 | Maintains | Buy | Get Alert |
| 04/02/2024 | HUM | Buy Now | Humana | $328.33 | 4.16% | B of A Securities | Kevin Fischbeck | $470 → $342 | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | HUM | Buy Now | Humana | $328.33 | — | Raymond James | John Ransom | — | Initiates | → Market Perform | Get Alert |
| 03/13/2024 | HUM | Buy Now | Humana | $328.33 | — | Argus Research | David Toung | — | Downgrade | Buy → Hold | Get Alert |
| 03/06/2024 | HUM | Buy Now | Humana | $328.33 | 8.43% | Barclays | Andrew Mok | → $356 | Initiates | → Equal-Weight | Get Alert |
| 01/30/2024 | HUM | Buy Now | Humana | $328.33 | 25.79% | Wells Fargo | Stephen Baxter | $465 → $413 | Maintains | Overweight | Get Alert |
| 01/29/2024 | HUM | Buy Now | Humana | $328.33 | 37.06% | Goldman Sachs | Nathan Rich | $515 → $450 | Maintains | Buy | Get Alert |
| 01/26/2024 | HUM | Buy Now | Humana | $328.33 | 21.83% | Mizuho | Ann Hynes | $550 → $400 | Maintains | Buy | Get Alert |
| 01/26/2024 | HUM | Buy Now | Humana | $328.33 | 19.09% | Cantor Fitzgerald | Sarah James | $597 → $391 | Downgrade | Overweight → Neutral | Get Alert |
| 01/26/2024 | HUM | Buy Now | Humana | $328.33 | 30.97% | Stephens & Co. | Scott Fidel | $550 → $430 | Maintains | Overweight | Get Alert |
| 01/26/2024 | HUM | Buy Now | Humana | $328.33 | 12.69% | UBS | Kevin Caliendo | $530 → $370 | Downgrade | Buy → Neutral | Get Alert |
| 01/26/2024 | HUM | Buy Now | Humana | $328.33 | 26.4% | RBC Capital | Ben Hendrix | $507 → $415 | Maintains | Outperform | Get Alert |
| 01/26/2024 | HUM | Buy Now | Humana | $328.33 | 37.06% | Goldman Sachs | Nathan Rich | $515 → $450 | Maintains | Buy | Get Alert |
| 01/25/2024 | HUM | Buy Now | Humana | $328.33 | 9.65% | Deutsche Bank | George Hill | $595 → $360 | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Humana (HUM)?
The latest price target for Humana (NYSE: HUM) was reported by Cantor Fitzgerald on April 10, 2024. The analyst firm set a price target for $391.00 expecting HUM to rise to within 12 months (a possible 19.09% upside). 55 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Humana (HUM)?
The latest analyst rating for Humana (NYSE: HUM) was provided by Cantor Fitzgerald, and Humana reiterated their neutral rating.
When was the last upgrade for Humana (HUM)?
The last upgrade for Humana Inc happened on December 12, 2023 when Argus Research raised their price target to $550. Argus Research previously had a hold for Humana Inc.
When was the last downgrade for Humana (HUM)?
The last downgrade for Humana Inc happened on April 2, 2024 when B of A Securities changed their price target from $470 to $342 for Humana Inc.
When is the next analyst rating going to be posted or updated for Humana (HUM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humana was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating Humana (HUM) correct?
While ratings are subjective and will change, the latest Humana (HUM) rating was a reiterated with a price target of $0.00 to $391.00. The current price Humana (HUM) is trading at is $328.33, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.